Underwriting AgreementUnderwriting Agreement • October 30th, 2017 • Synovus Financial Corp • National commercial banks • New York
Contract Type FiledOctober 30th, 2017 Company Industry JurisdictionSynovus Financial Corp., a Georgia corporation (the “Company”) confirms its agreement with Merrill Lynch, Pierce, Fenner & Smith Incorporated (the “Representative”) on behalf of the several Underwriters listed in Schedule I hereto (together, the “Underwriters”), with respect to the issue and sale by the Company, and the purchase by the Underwriters, acting severally and not jointly, of the respective principal amounts set forth in Schedule I of $300,000,000 in aggregate principal amount of the Company’s 3.125% Senior Notes due November 1, 2022 (the “Securities”). The Securities are to be issued pursuant to an indenture dated as of February 13, 2012 between the Company and the Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”), (“Indenture”).
Insulet Corporation 3,000,000 Shares Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • December 8th, 2010 • Insulet Corp • Surgical & medical instruments & apparatus • New York
Contract Type FiledDecember 8th, 2010 Company Industry Jurisdiction
Fidelity National Financial, Inc. Underwriting AgreementUnderwriting Agreement • May 5th, 2010 • Fidelity National Financial, Inc. • Title insurance • New York
Contract Type FiledMay 5th, 2010 Company Industry JurisdictionBanc of America Securities LLC J.P. Morgan Securities Inc. As Representatives of the several Underwriters listed in Schedule 1 hereto c/o Banc of America Securities LLC One Bryant Park New York, New York 10036 c/o J.P. Morgan Securities Inc. 383 Madison Avenue New York, New York 10179
JARDEN CORPORATION 8% Senior Notes due 2016 Underwriting AgreementUnderwriting Agreement • April 29th, 2009 • Jarden Corp • Wholesale-miscellaneous nondurable goods • New York
Contract Type FiledApril 29th, 2009 Company Industry JurisdictionJarden Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom the addressees listed above (the “Representatives”) are acting as representatives, $300,000,000 aggregate principal amount of its 8% Senior Notes due 2016 (the “Notes”). The Notes will be unconditionally guaranteed (the “Guarantees” and, together with the Notes, the “Securities”) on a joint and several basis by certain of the subsidiaries of the Company listed on Schedule 3 hereto (the “Guarantors”). The Securities will be issued pursuant to an Indenture to be dated as of April 30, 2009 (the “Base Indenture”) between the Company, the Guarantors and The Bank of New York Mellon, as trustee (the “Trustee”) as supplemented by a Supplemental Indenture thereto, to be dated as of the Closing Date (as defined herein) (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), between the Company,
SYNTHESIS ENERGY SYSTEMS, INC. 10,000,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • June 6th, 2008 • Synthesis Energy Systems Inc • Miscellaneous products of petroleum & coal • New York
Contract Type FiledJune 6th, 2008 Company Industry Jurisdiction
Mellanox Technologies, Ltd. 6,000,000 Shares of Ordinary Shares Underwriting AgreementUnderwriting Agreement • February 1st, 2007 • Mellanox Technologies, Ltd. • Semiconductors & related devices • New York
Contract Type FiledFebruary 1st, 2007 Company Industry JurisdictionMellanox Technologies, Ltd., an Israeli company (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 6,000,000 ordinary shares, par value NIS 0.0175 per share, of the Company (the “Underwritten Shares”), and, at the option of the Underwriters, up to an additional 900,000 ordinary shares of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The ordinary shares of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock.”
Volcano Corporation 6,800,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • August 9th, 2006 • Volcano CORP • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledAugust 9th, 2006 Company Industry JurisdictionVolcano Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 6,800,000 shares of common stock, par value $0.001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,020,000 shares of common stock, par value $0.001 per share, of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock, par value $0.001 per share, of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”. The Stock, including the Shares, will have attached thereto rights (the “Rights”) to purchase Series A Junior Participating Preferred Stock. The Rights are to be issued pursuant to a Rights Agreement (the “Rights Agreement”)
Volcano Corporation _____Shares of Common Stock Underwriting AgreementUnderwriting Agreement • May 24th, 2006 • Volcano CORP • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledMay 24th, 2006 Company Industry JurisdictionVolcano Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of ___shares of common stock, par value $0.01 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional ___shares of common stock, par value $0.01 per share, of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock, par value $0.01 per share of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”. The Stock, including the Shares, will have attached thereto rights (the “Rights”) to purchase Series A Junior Participating Preferred Stock. The Rights are to be issued pursuant to a Rights Agreement (the “Rights Agreement”) dated as of ___, 2
Underwriting AgreementUnderwriting Agreement • August 2nd, 2004 • Polypore International, Inc. • Miscellaneous chemical products • New York
Contract Type FiledAugust 2nd, 2004 Company Industry JurisdictionPolypore International, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule I hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 20,000,000 shares of common stock, par value $0.01 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 3,000,000 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”.